Effect of Everolimus-Eluting Stents in Different Vessel Sizes (from the Pooled FUTURE I and II Trials)

American Journal of Cardiology

Volumn 98, Issue 4, 2006, Pages 464-469

  Tsuchiya, Yoshihiro ^a   Lansky, Alexandra J ^a   Costa, Ricardo A ^a   Mehran, Roxana ^a   Pietras, Cody ^a   Shimada, Yoshihisa ^b   Sonoda, Shinjo ^b   Cristea, Ecaterina ^a   Negoita, Manuela ^a   Dangas, George D ^a   Moses, Jeffrey W ^a   Leon, Martin B ^a   Fitzgerald, Peter J ^b   Müller, Ralf ^c   Störger, Hans ^d   Hauptmann, Karl E ^e   Grube, Eberhard ^c  

^a NewYork Presbyterian Hospital   (United States)

^b STANFORD UNIVERSITY MEDICAL CENTER   (United States)

^c Heart Center Siegburg   (Germany)

^d Red Cross Hospital Cardiology Center   (Germany)

^e KRANKENHAUS DER BARMHERZIGEN BRÜDER   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

EVEROLIMUS;

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTERY DIAMETER; ARTERY INTIMA PROLIFERATION; ARTERY THROMBOSIS; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORONARY STENT; DRUG EFFECT; FEMALE; FOLLOW UP; HEART ANEURYSM; HUMAN; INTRAVASCULAR ULTRASOUND; MALE; MULTICENTER STUDY; OUTCOME ASSESSMENT; PHASE 1 CLINICAL TRIAL; PHASE 2 CLINICAL TRIAL; PREOPERATIVE PERIOD; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUANTITATIVE ANALYSIS; STATISTICAL SIGNIFICANCE;

AGED; BLOOD VESSEL PROSTHESIS IMPLANTATION; COATED MATERIALS, BIOCOMPATIBLE; CORONARY ANGIOGRAPHY; CORONARY RESTENOSIS; CORONARY VESSELS; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; PROSTHESIS DESIGN; SIROLIMUS; STENTS; TREATMENT OUTCOME; ULTRASONOGRAPHY, INTERVENTIONAL;

EID: 33746853013     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2006.02.054     Document Type: Article

References (9)

1. Eisen H.J., Tuzcu E.M., Dorent R., Kobashigawa J., Mancini D., Valantine-von Kaeppler H.A., Starling R.C., Sorensen K., Hummel M., Lind J.M., et al. Everolimus for the prevention of allograft rejection and vasculopathy in cardiac-transplant recipients. N Engl J Med 349 (2003) 847-858
2. Grube E., Sonoda S., Ikeno F., Honda Y., Kar S., Chan C., Gerckens U., Lansky A.J., and Fitzgerald P.J. Six- and twelve-month results from first human experience using everolimus-eluting stents with bioabsorbable polymer. Circulation 109 (2004) 2168-2171
3. Costa R.A., Lansky A.J., Mintz G.S., Mehran R., Tsuchiya Y., Negoita M., Gilutz Y., Nikolsky E., Fahy M., Pop R., et al. Angiographic results of the first human experience with everolimus-eluting stents for the treatment of coronary lesions (the FUTURE I trial). Am J Cardiol 95 (2005) 113-116
4. Kuntz R.E., Gibson C.M., Nobuyoshi M., and Baim D.S. Generalized model of restenosis after conventional balloon angioplasty, stenting and directional atherectomy. J Am Coll Cardiol 21 (1993) 15-25
5. Koning R., Eltchaninoff H., Commeau P., Khalife K., Gilard M., Lipiecki J., Coste P., Bedossa M., Lefevre T., Brunel P., et al. Stent placement compared with balloon angioplasty for small coronary arteries. in-hospital and 6-month clinical and angiographic results. Circulation 104 (2001) 1604-1608
6. Doucet S., Schalij M.J., Vrolix M.C., Hilton D., Chenu P., de Bruyne B., Udayachalerm W., Seth A., Bilodeau L., Reiber J.H., et al. Stent placement to prevent restenosis after angioplasty in small coronary arteries. Circulation 104 (2001) 2029-2033
7. Kastrati A., Schomig A., Dirschinger J., Mehilli J., Dotzer F., von Welser N., and Neumann F.J. A randomized trial comparing stenting with balloon angioplasty in small vessels in patients with symptomatic coronary artery disease. ISAR-SMART Study Investigators Intracoronary Stenting or Angioplasty for Restenosis Reduction in Small Arteries. Circulation 102 (2000) 2593-2598
8. Schuler W., Sedrani R., Cottens S., Haberlin B., Schulz M., Schuurman H.J., Zenke G., Zerwes H.G., and Schreier M.H. SDZ RAD, a new rapamycin derivative. pharmacological properties in vitro and in vivo. Transplantation 64 (1997) 36-42
9. Regar E., Serruys P.W., Bode C., Holubarsch C., Guermonprez J.L., Wijns W., Bartorelli A., Constantini C., Degertekin M., Tanabe K., et al. Angiographic findings of the multicenter Randomized Study With the Sirolimus-Eluting Bx Velocity Balloon-Expandable Stent (RAVEL). sirolimus-eluting stents inhibit restenosis irrespective of the vessel size. Circulation 106 (2002) 1949-1956